Too Many Cooks in the Kitchen?

by Stacy L. Ehrlich, Partner with the Law firm of Kleinfeld, Kaplan and Becker LLP, Washington, DC

and

Reena P. Raman, Associate with the Law firm of Kleinfeld, Kaplan and Becker LLP, Washington, DC

Retailers on the Radar of FDA Under the Family Smoking Prevention
and Tobacco Control Act

by Ricardo Carvajal, Of Counsel with the law firm of Hyman, Phelps & McNamara, PC, Washington, DC

and

David Clissold, Director of the law firm of Hyman, Phelps & McNamara, PC, Washington, DC

Family Smoking Prevention and Tobacco Control Act:
Implications for the Law Enforcement Community

by Colleen McCue, President and Chief Executive Officer of MC2 Solutions, LLC,
Midlothian, VA

and

Richard Carchman, with the Tobacco Regulatory Working Group, Columbia, VA

and

Barbara K. Zedler, Chief Medical Officer of Venebio, LLC, Richmond, VA

and

Richard J. McCue, Supervisory Special Agent (retired), Vice President & COO of MC2 Solutions, LLC, Midlothian, VA

FDA Regulation of Tobacco: The Dog That Caught the Bus?

by Michael H. Hinckle, Partner in the law firm of K&L Gates LLP, Research Triangle Park, NC

and

Scott R. Hovey, Associate in the law firm of K&L Gates LLP, Research Triangle Park, NC

The Tobacco Industry’s Lawsuit Against the New FDA Tobacco Law

by Matthew L. Myers, President, Campaign for Tobacco-Free Kids, Washington, DC

Cutting-Edge Issues Showcased at FDLI Advertising and Promotion Conference

by Abby Foster, Managing Editor, the Food and Drug Law Institute, Washington, DC

21st Century Toxicology and its Implications for FDA Regulation of Food-Contact Substances

by Jane Muncke, Environmental Toxicologist with Emhart Glass SA, Switzerland

and

Stephen Paul Mahinka, Partner and Chair of the Life Sciences Practice in the Law firm of Morgan, Lewis & Bockius LLP, Washington, DC

Drug Price Regulation and Market Access: Developments in Canada

by Adrienne Blanchard, Partner in the Law firm of Gowling Lafleur Henderson, LLP, Ottawa, Canada

and

Martin Mason, Partner in the Law firm of Gowling Lafleur Henderson, LLP, Ottawa, Canada

Navigating the FDA Process: Patent Strategy for Combination Products

by Joanna T. Brougher, Registered Patent Attorney in the international law firm of Greenberg Traurig, LLP, Boston, MA

and

David J. Dykeman, Registered Patent Attorney and Shareholder in the international law firm of Greenberg Traurig, LLP, Boston, MA

 

Canadian Corner
Proposed Amendments to Adverse Drug Reaction Reporting in Canada

by Brian Daley, Partner in the Law firm of Ogilvy Renault, Montreal, Quebec, Canada

and

Julie Dallaire, Associate in the Law firm of Ogilvy Renault, Montreal, Canada

and

Miriam Cohen, Articling Student in the Law firm of Ogilvy Renault, Montreal, Canada

Global Corner
Nanotechnology Regulation: Could Differing Views in Europe Stifle Innovation?

by Matthew R. Weinberg, Chief Executive Officer, The Weinberg Group, Washington, DC (Carlos F. Peza, Consultant, coauthored this article)

Associates’ Corner
Food Advertising and Childhood Obesity: Will Industry Self-Regulation Make Weight or Will Congress and the FTC Try to Tip the Scales Through New Laws?

by Jody L. DeFord, Attorney with Ice Miller, LLP, Indianapolis, IN

Students Corner
FDA’s New Tobacco Authority and Promoting Smoking Cessation: Concert or Conflict?

by Meredith N. Larson, Managing Editor, Georgetown Journal of Gender and the Law, Vol. XI. She is a 2010 JD/MPH Candidate, Georgetown University Law Center, Johns Hopkins Bloomberg School of Public Health